Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ESPR: Esperion Therapeutics, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ESPR
The Story
ESPR
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+21.3% / yr
Operating margin
18.1%
ROIC
31.0%
Financially safe
Adequate
Debt / equity
-1.77×
Interest coverage
1.7×
Current ratio
1.53×
Esperion Therapeutics, Inc.
ESPR
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Esperion Therapeutics, Inc.
ESPR
NASDAQ
·
USD
·
Closed
$3.18
+0.00%
$3.18
+$0.00 (0.00%)
52W Range
67th
pctl
Volume
-
Mkt Cap
661.15M
USD
P/E
-131.4
TTM
Div Yield
99.37%
ann
52W Range
67th
pctl
Volume
-
Market Cap
661.15M
USD
P/E Ratio
-131.4
TTM
Div Yield
99.37%
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings